PERITONEAL CANCER
Clinical trials for PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets Platinum-Resistant ovarian cancer
Disease control Recruiting nowThis early-stage study tests a new drug called azenosertib (ZN-c3) combined with standard chemotherapy or bevacizumab in people with ovarian, peritoneal, or fallopian tube cancer that has stopped responding to platinum-based treatment. The goal is to find safe doses and see if th…
Matched conditions: PERITONEAL CANCER
Phase: PHASE1 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated May 26, 2026 10:02 UTC
-
New combo therapy aims to delay ovarian cancer return
Disease control Recruiting nowThis study tests whether adding a second drug (bevacizumab) to standard niraparib treatment helps keep advanced ovarian cancer from coming back longer. About 970 women with newly diagnosed advanced ovarian, fallopian tube, or peritoneal cancer will take part. The main goal is to …
Matched conditions: PERITONEAL CANCER
Phase: PHASE3 • Sponsor: AGO Study Group • Aim: Disease control
Last updated May 26, 2026 09:51 UTC
-
New drug combo aims to keep ovarian cancer at bay
Disease control Recruiting nowThis study tests whether combining two drugs, mirvetuximab soravtansine and olaparib, can effectively control recurrent ovarian, peritoneal, or fallopian tube cancer after initial treatment. About 53 women whose cancer responded to platinum-based chemotherapy will receive the dru…
Matched conditions: PERITONEAL CANCER
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New study aims to cut blood transfusions in ovarian cancer surgery
Disease control Recruiting nowThis study tests a technique called acute normovolemic hemodilution (ANH) during ovarian cancer surgery. ANH involves removing some blood before surgery and replacing it with fluids, then giving the blood back later. The goal is to see if this reduces the need for donor blood tra…
Matched conditions: PERITONEAL CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
Could a common painkiller boost ovarian cancer treatment?
Disease control Recruiting nowThis early-phase study is testing whether adding aspirin to standard chemotherapy can help the immune system fight ovarian, fallopian tube, or peritoneal cancer more effectively. About 100 women will receive aspirin alongside their chemo before surgery. Researchers will measure c…
Matched conditions: PERITONEAL CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New drug combo aims to extend remission in tough ovarian cancer
Disease control Recruiting nowThis study tests whether adding mirvetuximab soravtansine to standard bevacizumab maintenance therapy can delay cancer return in women with a specific type of recurrent ovarian, fallopian tube, or peritoneal cancer. About 520 adults whose cancer has a high level of a protein call…
Matched conditions: PERITONEAL CANCER
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Virtual reality goggles could be new tool against cancer pain
Symptom relief Recruiting nowThis study tests whether using virtual reality (VR) can reduce severe belly pain and improve daily life in people with digestive tract cancers. 360 participants will be randomly assigned to one of three groups: skills-based VR, distraction VR, or a sham VR. The goal is to see if …
Matched conditions: PERITONEAL CANCER
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
Mini device implanted in tumors could personalize cancer treatment
Knowledge-focused Recruiting nowThis early study is testing a small implantable device that sits inside a tumor and measures how different chemotherapy drugs work against ovarian, fallopian tube, and peritoneal cancers. About 20 people with advanced cancer will have the device placed and removed during standard…
Matched conditions: PERITONEAL CANCER
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 08:19 UTC
-
New study aims to unlock survival secrets in ovarian cancer
Knowledge-focused Recruiting nowThis study looks at 371 people with advanced ovarian, peritoneal, or fallopian tube cancer to find out which patient and tumor traits affect how long they live. Researchers will collect medical data and blood samples over 2 years. The goal is to build a database that helps doctor…
Matched conditions: PERITONEAL CANCER
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC